Physician profile
Roy Silver
NPI 1962465310
$57,102.98
in general payments reported to CMS, 2019-2025
22 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,429 · 2020: $3,511 · 2021: $42.50 · 2022: $9,473 · 2023: $28K · 2024: $15K · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Education: $10K · Consulting Fee: $10K · Travel and Lodging: $4,303 · Food and Beverage: $1,061.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,283.54 |
| Education | $10,000.00 |
| Consulting Fee | $10,000.00 |
| Travel and Lodging | $4,302.95 |
| Food and Beverage | $1,060.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $39,540.66 | 2022-2024 | |
| Intuitive Surgical, INC. | $11,851.46 | 2023-2024 | Davinci Xi, Da Vinci Surgical System |
| Clinical Innovations, LLC | $4,363.47 | 2019-2020 | |
| Abbvie INC. | $219.08 | 2019-2021 | |
| Hologic Sales and Service, LLC | $213.41 | 2019-2024 | Thinprep 2000 Processor |
| Coopersurgical, INC. | $171.03 | 2023-2025 | Summit Doppler, Supercut Hysterectomy Scissors, Sos |
| Myovant Sciences INC. | $130.64 | 2022 | |
| Allergan, INC. | $98.76 | 2019-2020 | |
| Medicem INC. | $69.64 | 2020-2022 | |
| Shield Therapeutics INC | $56.71 | 2023-2024 | Accrufer |
| Bayer Healthcare Pharmaceuticals INC. | $52.28 | 2019 | |
| Organon LLC | $48.25 | 2024 | |
| Biom'Up France Sas | $47.50 | 2020 | |
| Merck Sharp & Dohme LLC | $41.40 | 2020 | |
| Gilead Sciences, INC. | $29.54 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $29.09 | 2025 | Gemtesa |
| Sage Therapeutics, LLC | $28.77 | 2025 | Zurzuvae |
| Integra Lifesciences Corporation | $27.50 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Baxter Healthcare | $25.50 | 2024 | Tisseel |
| Conmed Corporation | $24.37 | 2025 | Airseal |
| Lupin INC. | $17.50 | 2020 | |
| Channel Medsystems, INC. | $16.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Silver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.